A Study on Risk Factors and Drug Utilisation Pattern in Acute Ischemic Stroke Patients

Background: Acute ischemic stroke (AIS) is associated with vascular, metabolic, and lifestyle-related risk factors, and its management involves several medication classes. Objective: To describe risk-factor profiles and drug utilisation among hospitalized patients with AIS. Methods: A six-month prospective observational study included 120 adults with computed tomography or magnetic resonance imaging-confirmed AIS at KIMS Hospital, Secunderabad. Demographic, comorbidity, social-history, and medication data were collected using structured forms and summarized with IBM SPSS version 24. Results: Mean age was 59.75 ± 13.8 years. The largest age group was 41–50 years (31 patients; 25.83%), and the results tables recorded 81 males (67.5%) and 39 females (32.5%). Hypertension with atrial fibrillation was the most frequent recorded comorbidity category (23; 19.17%), followed by hypertension with coronary artery disease (22; 18.33%). Alcohol use was recorded in 36 patients (30%), smoking in 30 (25%), and both in 20 (16.67%). Citicoline and pantoprazole were each prescribed to all 120 patients. Aspirin, clopidogrel, and aspirin-plus-clopidogrel were recorded in 50, 46, and 49 patients, respectively; atorvastatin and rosuvastatin in 63 and 57. Thrombolysis was recorded in 32 patients (26.6%). Conclusion: The cohort had substantial cardiovascular comorbidity and frequent exposure to antithrombotic, lipid-lowering, and supportive medicines. The findings describe local prescribing and risk profiles; patient-level assessment is needed to determine treatment appropriateness, safety, and clinical outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24170492
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Study on Risk Factors and Drug Utilisation Pattern in Acute Ischemic Stroke Patients

Dr. Sabahat Sakina, Vudayagiri Usha, Jalagam Saideepthi, Thota Varalaxmi et al.
Zenodo (CERN European Organization for Nuclear Research)
Acute Ischemic Stroke Management
article

A Study on Risk Factors and Drug Utilisation Pattern in Acute Ischemic Stroke Patients

Dr. Sabahat Sakina, Vudayagiri Usha, Jalagam Saideepthi, Thota Varalaxmi, Banoth Swarna
article en

Abstract

Background: Acute ischemic stroke (AIS) is associated with vascular, metabolic, and lifestyle-related risk factors, and its management involves several medication classes. Objective: To describe risk-factor profiles and drug utilisation among hospitalized patients with AIS. Methods: A six-month prospective observational study included 120 adults with computed tomography or magnetic resonance imaging-confirmed AIS at KIMS Hospital, Secunderabad. Demographic, comorbidity, social-history, and medication data were collected using structured forms and summarized with IBM SPSS version 24. Results: Mean age was 59.75 ± 13.8 years. The largest age group was 41–50 years (31 patients; 25.83%), and the results tables recorded 81 males (67.5%) and 39 females (32.5%). Hypertension with atrial fibrillation was the most frequent recorded comorbidity category (23; 19.17%), followed by hypertension with coronary artery disease (22; 18.33%). Alcohol use was recorded in 36 patients (30%), smoking in 30 (25%), and both in 20 (16.67%). Citicoline and pantoprazole were each prescribed to all 120 patients. Aspirin, clopidogrel, and aspirin-plus-clopidogrel were recorded in 50, 46, and 49 patients, respectively; atorvastatin and rosuvastatin in 63 and 57. Thrombolysis was recorded in 32 patients (26.6%). Conclusion: The cohort had substantial cardiovascular comorbidity and frequent exposure to antithrombotic, lipid-lowering, and supportive medicines. The findings describe local prescribing and risk profiles; patient-level assessment is needed to determine treatment appropriateness, safety, and clinical outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon